Oruka Therapeutics (ORKA) Payables (2010 - 2026)
Oruka Therapeutics (ORKA) recorded Payables of $7.95 million in Q2 2026, up 70.5% from $4.66 million a year earlier and up 117.1% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Oruka Therapeutics reported Payables of $4.16 million, up 20.0% from FY2024.
- Annual Payables has increased for three straight years, with a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- Across earlier years, Payables came in at $3.46 million in FY2024 (+856.4%), $362,000 in FY2023 (+8.4%), $334,000 in FY2022 (-70.1%) and $1.12 million in FY2021 (-37.0%).
- The Q2 2026 figure is the highest quarterly Payables in data going back to Q4 2010.
- On a year-over-year basis, Payables has increased for three consecutive quarters, with growth averaging 313.6% over the last seven quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 856.4% in Q4 2024, against a decline of 78.3% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.66 million (Q1 2026), $4.16 million (Q4 2025) and $2.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Oruka Therapeutics | 5.29 Bn | 3.34 Bn | - | 7.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.95 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 4.16 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 3.55 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 571,000.00 |
| Mar 31, 2024 | 529,000.00 |
| Dec 31, 2023 | 362,000.00 |
| Sep 30, 2023 | 322,000.00 |
| Jun 30, 2023 | 241,000.00 |
| Mar 31, 2023 | 366,000.00 |
| Dec 31, 2022 | 334,000.00 |
| Sep 30, 2022 | 593,000.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.13 Mn |
API Access
Oruka Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();